Review Article| Volume 37, ISSUE 2, P245-259, April 2023

Introduction to the Thalassemia Syndromes

Molecular Medicine’s Index Case


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Hematology/Oncology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Steinberg M.H.
        • Benz Jr., E.J.
        • Adewoye A.H.
        • et al.
        Pathobiology of the Human Erythrocyte and its Hemoglobins, Chapter 33.
        in: Hoffman R. Benz Jr., E.J. Silberstein L.E. Hematology: Principles and practice. 7th edition. Elsevier, Philadelphia, PA2018: 447-457
        • Benz Jr., E.J.
        • Forget B.G.
        The Molecular Genetics of the Thalassemia syndromes.
        Prog Hematol. 1975; 9: 107-155
        • Chapin J.
        • Giardina P.J.
        Thalassemia syndromes, Chapter 40.
        in: Hoffman R. Benz Jr, E.J. Silberstein L.E. Hematology: principles and practice. 7th edition. Elsevier, Philadelphia2016: 546-570
        • Traeger Synodinos J.
        • Papassotiriou I.
        • Metaxatou-Maurommati A.
        • et al.
        Distinct phenotypic expression associated with a new hyper-unstable alpha globin variant α1cd37(C2) Pro>0: Comparison to other α thalassemic hemoglobinopathies.
        Blood Cells Mol Dis. 2000; 4: 276-284
        • Clegg J.B.
        • Weatherall D.J.
        • Milner P.F.
        Haemoglobin constant spring: an alpha chain termination mutant?.
        Nature. 1971; 5328: 337-340
        • Chan W.Y.K.
        • Lee P.P.W.
        • Lee V.
        • et al.
        Outcomes of allogeneic transplantation for hemoglobin barts hydrops fetalis syndrome in Hong Kong.
        Pediatr Transplant. 2021; 25: e14037
        • Ingram V.
        Sickle Cell Anemia: The Molecular Biology of the First “Molecular Disease”. The Crucial Importance of Serendipity.
        Genetics. 2004; 167: 1-7
        • Weatherall D.J.
        • Clegg J.B.
        • Naughton M.A.
        Globin synthesis in Thalassaemia: an in vitro Study.
        Nature. 1965; 208: 1061-1065
        • Neinhuis A.W.
        • Anderson W.F.
        Isolation and Translation of Hemoglobin Messenger RNA from Thalassemia, sickle cell anemia, and normal human reticulocytes.
        J Clin Invest. 1971; 50: 2460-2466
        • Benz Jr., E.J.
        • Forget B.G.
        Defect in messenger RNA for human hemoglobin in beta thalassemia.
        J Clin Inves. 1971; 50: 2755-2761
        • Housman D.
        • Skoultchi A.
        • Forget B.G.
        • et al.
        Quantitative deficiency of chain specific globin messenger ribonucleic acids in the thalassemia syndromes.
        Proc Natl Acad Sci, USA. 1973; 70: 1809-1813
        • Kacian D.L.
        • Gambino R.
        • Dow L.W.
        • et al.
        Decreased globin messenger RNA in thalassemia detected by molecular hybridization.
        Proc Natl Acad Sci, USA. 1973; 70: 1886-1890
        • Steinberg M.H.
        • Forget B.G.
        • Higgs D.R.
        • et al.
        Disorders of human hemoglobin.
        1st edition. Cambridge University Press, New York2000
        • Maquat L.E.
        • Kinniburgh A.J.
        • Rachmilewitz E.A.
        • et al.
        Unstable beta globin mRNA in mRNA deficient beta zero thalassemia.
        Cell. 1981; 27: 543-545